Position in LEGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,649,966
+$2,432,443 QoQ
Shares Held
195,636
+10.0% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 217 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LEGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. LEGN ranks #136 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in LEGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,649,966 | 195,636 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,217,523 | 177,862 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $6,250,879 | 287,529 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $11,790,435 | 361,559 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $9,084,940 | 255,986 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,709,703 | 168,279 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $23,123,766 | 710,626 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $11,853,081 | 243,240 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $14,249,995 | 321,743 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $22,971,825 | 409,553 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $20,914,427 | 347,589 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $18,227,517 | 271,364 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $18,576,522 | 269,108 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $21,934,504 | 454,884 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $11,829,988 | 236,979 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $16,083,560 | 394,205 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $15,014,450 | 272,990 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $9,448,216 | 259,995 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,537,621 | 97,353 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $216,497 | 4,282 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $579,788 | 14,124 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $294,668 | 10,154 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,548 | 55 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $1,697 | 55 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||